Literature DB >> 6144460

Anti-anxiety agents: duration of use and characteristics of users in the U.S.A.

G D Mellinger, M B Balter, E H Uhlenhuth.   

Abstract

A national survey of psychotherapeutic drug use was carried out in the U.S.A. in 1979. Data were obtained from a probability sample (n = 3161) of adults in the general population, using a clinically-oriented interview lasting an average of 90 minutes. The data provide estimates of the prevalence of using anxiolytic and other psychotherapeutic medications. Among users they also provide detailed descriptions of patterns of use and characteristics associated with various patterns of use. The study found that 11% of American adults used an anxiolytic during the 12 months prior to the survey. Benzodiazepines accounted for 84% of the anxiolytics mentioned. The analyses compared (i) users of anxiolytics with non-users and (ii) three groups of anxiolytic users classified according to pattern (frequency and regularity) of use. The results were generally consistent with an illness treatment model of psychotherapeutic drug use, and they raise interesting questions about short-term single-occasion use.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144460     DOI: 10.1185/03007998409109542

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  11 in total

1.  Initial benzodiazepine use and improved health-related quality of life.

Authors:  Rolf van Hulten; Bart Teeuw; Albert Bakker; Hubert G Leufkens
Journal:  Pharm World Sci       Date:  2005-02

2.  Usage patterns of benzodiazepines in a Dutch community: a 10-year follow-up.

Authors:  R van Hulten; H G Leufkens; A Bakker
Journal:  Pharm World Sci       Date:  1998-04

3.  Patients, prescribing, and benzodiazepines.

Authors:  L Nolan; K O'Malley
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Benzodiazepine prescriptions and therapist non-compliance.

Authors:  B Geiselmann; M Linden; N Sachs-Ericsson
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Clinical and economic evaluation of benzodiazepines: a value analysis.

Authors:  J S Lyons; D B Larson; J Hromco
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

6.  Commentary on review by Woods and Winger. Benzodiazepines: long-term use among patients is a concern and abuse among polydrug abusers is not trivial.

Authors:  R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 7.  Current benzodiazepine issues.

Authors:  J H Woods; G Winger
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

8.  Sex differences among recipients of benzodiazepines in Dutch general practice.

Authors:  F W van der Waals; J Mohrs; M Foets
Journal:  BMJ       Date:  1993-08-07

9.  The use of sedative-hypnotic drugs in a university teaching hospital.

Authors:  R O'Reilly; C Rusnak
Journal:  CMAJ       Date:  1990-03-15       Impact factor: 8.262

Review 10.  The use of microcomputer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: a review with emphasis on temazepam.

Authors:  G W Kunsman; J E Manno; B R Manno; C M Kunsman; M A Przekop
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.